Chronic paroxysmal hemicrania in paediatric age: report of two cases

J Headache Pain. 2011 Apr;12(2):263-7. doi: 10.1007/s10194-011-0315-7. Epub 2011 Feb 22.

Abstract

Chronic paroxysmal hemicrania (CPH) is a rare primary headache syndrome, which is classified along with hemicrania continua and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) as trigeminal autonomic cephalalgia (TACs). CPH is characterised by short-lasting (2-30 min), severe and multiple (more than 5/day) pain attacks. Headache is unilateral, and fronto-orbital-temporal pain is combined with cranial autonomic symptoms. According to the International Classification of Headache Disorders, 2nd edition, the attacks are absolutely responsive to indomethacin. CPH has been only rarely and incompletely described in the developmental age. Here, we describe two cases concerning a 7-year-old boy and a 11-year-old boy with short-lasting, recurrent headache combined with cranial autonomic features. Pain was described as excruciating, and was non-responsive to most traditional analgesic drugs. The clinical features of our children's headache and the positive response to indomethacin led us to propose the diagnosis of CPH. Therefore, our children can be included amongst the very few cases of this trigeminal autonomic cephalgia described in the paediatric age.

Publication types

  • Case Reports

MeSH terms

  • Age Factors
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Child
  • Cyclooxygenase Inhibitors / administration & dosage
  • Drug Administration Schedule
  • Humans
  • Indomethacin / administration & dosage*
  • Male
  • Paroxysmal Hemicrania / diagnosis
  • Paroxysmal Hemicrania / drug therapy*
  • Paroxysmal Hemicrania / physiopathology
  • Secondary Prevention
  • Trigeminal Autonomic Cephalalgias / diagnosis
  • Trigeminal Autonomic Cephalalgias / drug therapy*
  • Trigeminal Autonomic Cephalalgias / physiopathology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Indomethacin